Pharmacy

Vallergan Forte Syrup Generic Trimeprazine Tartarate

Home » Prescription Drugs 16 » Vallergan Forte Syrup Generic Trimeprazine Tartarate

IndicationsVallergan Forte is used in:Urticaria and pruritus. Premedication for anaesthesia. Dosage and AdministrationVallergan Forte is not recommended for infants less than two years of age.Urticaria and PruritusAdults10 mg two or three times daily. Up to 100 mg per day has been used in intractable cases.ElderlyDosage should be reduced to 10 mg once or twice daily.Children2.5 to 5 mg three or four times daily.Pre-anaesthetic MedicationChildren (2 to 7 years of age)The maximum dosage of Vallergan Forte syrup recommended for this indication is 2 mg/kg bodyweight.

Buy Vallergan Forte Syrup Generic Trimeprazine Tartarate and other Prescription Drugs 16 products online at Medstore.

Buy Online at Medstore - Click Here!

About Vallergan Forte Syrup Generic Trimeprazine Tartarate:

Product Type: Prescription Drugs 16

Vallergan Forte Syrup ( Generic Trimeprazine Tartarate )

Vallergan Forte Syrup (Generic Trimeprazine Tartarate)

Generic Trimeprazine Tartarate

30mg/5mL Generic Trimeprazine Tartarate Vallergan Forte Syrup

View more Prescription Drugs 16

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.